Clinical Effect of Azithromycin Combined with Erythromycin in the Treatment of Children with Mycoplasma Pneumonia

LlAO Hongbin; WEN Qiqin; MING Huaizhi; LI Daibi

Abstract：Objective To study clinical effect of azithromycin combined with erythromycin in the treatment of children with myco-plasma pneumonia. Methods Children with mycoplasma pneumonia who came to our hospital for treatment from January 2014 to De-cember 2014 were randomly selected and divided into study group and control group, 46 cases in each group. Children in study group were treated with azithromycin combined with erythromycin, while those in control group were treated with azithromycin only. The clin-ical therapeutic effects of two groups were compared. Results After treatment, the total effective cases of the study group were 43 and the total effective rate was 93. 48% (43/46). While the total effective cases of control group were 36 and the total effective rate was 78. 26% (36/46). The difference between the two groups is statistically significant (P<0. 05) . The average time of abatement of fe-ver, relief of cough and absence of pulmonary rales, and hospitalization cost in the study group were less than those of the control group, with statistically significant difference (P<0. 05). The adverse reaction rate of the study group was 23. 91% (11/46), while that of the control group was 19. 57% (9/46), with no statistically significant difference (P>0. 05). Conclusion The use of Az-ithromycin combined with Erythromycin in the treatment of children with mycoplasma pneumonia proves significantly effective. It can ease the clinical symptoms quickly and is safer. It is worthy of further clinical research and wider application.